Akums Drugs and Pharmaceuticals Pre-IPO - Profitable but Needs to Scale up More
116 Views24 Jul 2024 11:30
Akums Drugs and Pharmaceuticals (0200361D IN) is looking to raise up to US$239m in its upcoming India IPO. In this note, we talk about the company’s historical performance.
What is covered in the Full Insight:
- Company Background
- Revenue Drivers
- Client Base and Relationships
- Industry Growth and Government Support
- Financial Performance and Risks
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Akums Drugs and Pharmaceuticals Pre-IPO - Profitable but Needs to Scale up More24 Jul 2024
- Akums Drugs and Pharmaceuticals Pre-IPO Tearsheet26 Feb 2024
x